SynTheAll Pharmaceutical Co.'s IPO

SynTheAll Pharmaceutical Co. raised a round of funding on April 03, 2015. Investors include Public.

SynTheAll Pharmaceutical Co. (STA) provides process chemistry services and manufactures small-molecule advanced intermediates and APIs for customer use in preclinical and clinical trials and for marke…

Articles about SynTheAll Pharmaceutical Co.'s IPO: